Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Schizophrenia
Interventions
DRUG

Dextroamphetamine

Each participant receives a single pill of placebo or active drug (dextroamphetamine 10 mg) and completes approximately 6 hours of testing in the laboratory. One week later, that participant receives a single pill of the alternate comparator and is again tested in the laboratory. Thus, in total, each participant receives one placebo pill and one active pill, separated by one week.

DRUG

Placebo

Each participant receives a single pill of placebo or active drug (dextroamphetamine 10 mg) and completes approximately 6 hours of testing in the laboratory. One week later, that participant receives a single pill of the alternate comparator and is again tested in the laboratory. Thus, in total, each participant receives one placebo pill and one active pill, separated by one week.

Trial Locations (1)

92103

Clinical Teaching Facility (CTF-B102) at UCSD Medical Center, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02634684 - Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia. | Biotech Hunter | Biotech Hunter